Our semaglutide for UK research markets is a high-purity peptide compound with triple agonist activity targeting GCGR, GIPR and GLP-1 receptors. This pharmaceutical grade material is supplied as lyophilized powder for research applications.
The semaglutide for UK laboratories demonstrates potent activity with EC50 values of 5.79 nM (GCGR), 0.0643 nM (GIPR) and 0.775 nM (GLP-1R) in human receptors. In metabolic studies, semaglutide for UK research purposes has shown significant effects on glucose tolerance, energy expenditure and weight management.
Key research applications of our semaglutide for UK include:
Proper storage is essential for maintaining peptide integrity. Store in cool, dry conditions protected from light. Avoid repeated freeze-thaw cycles and prolonged solution storage. Aliquot according to experimental requirements.